Statistics

Total Visits

Views
A multicenter randomized study comparing temozolomide (TMZ) versus TMZ-plus-bevacizumab (BEV) before standard treatment in unresectable glioblastoma (GBM) patients (p): The GENOM 009 study by the GEINO group11

Select a period of time:

Number of views in the range

Views
A multicenter randomized study comparing temozolomide (TMZ) versus TMZ-plus-bevacizumab (BEV) before standard treatment in unresectable glioblastoma (GBM) patients (p): The GENOM 009 study by the GEINO group6

Views

Views
November 20230
December 20231
January 20242
February 20240
March 20241
April 20241
May 20241
Download CSV file
 untranslated
 untranslated

Top country views

Views
United States5
Spain1
 

Top cities views

Views
Boardman2
Chicago1
Santiago de Compostela1